✦ LIBER ✦

Second-line systemic therapy for the treatment of metastatic renal cell cancer

✍ Scribed by Kruck, Stephan ;Bedke, Jens ;Kuczyk, Markus A ;Merseburger, Axel S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-Line Treatment Outcomes After Fir

✍ Chi-Chang Chen; Gregory P. Hess; Zhimei Liu; Dean H. Gesme; Sanjiv S. Agarwala; 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 284 KB

Biological therapy for metastatic renal

📂 Article 📅 1991 🏛 The Lancet 🌐 English ⚖ 324 KB

PCN101 Cost Effectiveness of Everolimus

✍ J. Mihajlović; P. Pechlivanoglou; A. Sabo; Z. Tomić; M.J. Postma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Second-line systemic therapy and emergin

✍ Guru Sonpavde; Cora N Sternberg; Jonathan E Rosenberg; Noah M Hahn; Matthew D Ga 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 299 KB

Systemic Treatment Options for Untreated

✍ Molina, Ana M.; Motzer, Robert J.; Heng, Daniel Y. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Second-line everolimus treatment in adva

✍ Vicki Brower 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 57 KB